Parameter | Â | Univariate analysis | Â | Â | Multivariate analysis | Â |
---|---|---|---|---|---|---|
 | Odds ratio | 95% CI | p value | Odds ratio | 95% CI | p value |
CA9 expression in CNB | Â | Â | Â | Â | Â | Â |
positive vs negative | 0.24 | 0.09-0.63 | 0.041 | 0.21 | 0.07-0.59 | 0.003 |
ER | Â | Â | Â | Â | Â | Â |
positive vs negative | 0.24 | 0.10-0.61 | 0.002 | 0.23 | 0.02-2.37 | 0.219 |
PgR | Â | Â | Â | Â | Â | Â |
positive vs negative | 0.22 | 0.08-0.61 | 0.004 | 0.36 | 0.10-1.30 | 0.120 |
HER2 | Â | Â | Â | Â | Â | Â |
positive vs negative | 1.75 | 0.68-4.48 | 0.244 | Â | Â | Â |
Molecular subtypes | Â | Â | Â | Â | Â | Â |
HR+/HER2- vs others | 0.33 | 0.13-0.83 | 0.018 | 1.78 | 0.18-17.44 | 0.622 |
HR-/HER2+ vs others | 0.02 | 0.01-2999894 | 0.728 | Â | Â | Â |
HR-/HER2+ vs others | 1.75 | 0.683-4.483 | 0.244 | Â | Â | Â |
HR-/HER2- vs others | 1.17 | 0.93-1.46 | 0.176 | Â | Â | Â |
Age | Â | Â | Â | Â | Â | Â |
≥55 vs <55 | 0.88 | 0.37-2.05 | 0.759 |  |  |  |
Menopause | Â | Â | Â | Â | Â | Â |
positive vs negative | 0.82 | 0.33-2.05 | 0.677 | Â | Â | Â |
Tumor size | Â | Â | Â | Â | Â | Â |
≥4 cm vs <4 cm | 0.64 | 0.19-2.12 | 0.463 |  |  |  |
Lymph node status | Â | Â | Â | Â | Â | Â |
positive vs negative | 4.33 | 0.93-20.1 | 0.061 | Â | Â | Â |